Computer techniques for drug development from Thai traditional medicine
Chak Sangma1, Daungmanee Chuakheaw, Nipa Jonkon
1Department of Chemistry, Kasetsart University, Chatuchak, Bangkok, Thailand. fscicsm@ku.ac.th
Current Pharmaceutical Design
|March 13, 2010
Summary
Researchers are developing new drugs from Thai medicinal plants by digitizing traditional knowledge. This approach uses computer-aided drug discovery to identify potential treatments for diseases like HIV and cancer.
Area of Science:
- Ethnobotany and Pharmacology
- Computational Chemistry and Cheminformatics
- Drug Discovery and Development
Background:
- Thailand possesses abundant plant species, with traditional medicine recognizing over 3000 for potential biological activity.
- Despite years of research, modern drug discovery methods are underutilized for validating and accelerating the identification of new drugs from Thai flora.
- Challenges exist in tracing traditional Thai medicinal knowledge to its original sources due to oral traditions and ancient texts.
Purpose of the Study:
- To create digital databases (Chemiebase and THRAI) for Thai medicinal plants and their associated traditional knowledge.
- To apply computer-aided drug discovery (CADD) methods to rationalize and expedite the drug discovery process using ethnobotanical data.
- To present examples of CADD applications, including virtual screening, molecular modeling, and toxicity assessment, for compounds derived from Thai medicinal plants.
Main Methods:
- Development of the Chemiebase structural database for virtual screening of Thai medicinal plant compounds.
- Establishment of the Thai Herbal Repository Access Initiative (THRAI) database to compile and digitize traditional knowledge.
- Application of virtual screening for anti-HIV-1 reverse transcriptase, anti-HIV-1 protease, anti-influenza A neuraminidase, and anti-cyclooxygenase (COX) targets.
- Utilizing molecular modeling for proposing drug mechanisms of anti-tumor compounds.
- Conducting toxicity assessments for selected compounds from Thai medicinal plants.
Main Results:
- Successful compilation of traditional knowledge into electronic formats suitable for drug design via the THRAI database.
- Identification of potential drug candidates through virtual screening against various disease targets.
- Elucidation of potential drug mechanisms for anti-tumor compounds using molecular modeling.
- Evaluation of the safety profile of compounds through toxicity assessments.
Conclusions:
- Digital databases and CADD methods offer a powerful approach to validate and accelerate drug discovery from Thai medicinal plants.
- Integrating traditional knowledge with modern computational techniques can unlock the therapeutic potential of Thailand's rich botanical resources.
- This research provides a framework for rational drug design based on ethnopharmacological data, paving the way for novel therapeutic agents.
Related Concept Videos
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
